Navigation Links
UC San Diego's Karin receives prestigious Harvey Prize
Date:9/8/2010

Michael Karin, PhD, Distinguished Professor of Pharmacology and Pathology at the University of California, San Diego School of Medicine has been awarded the 2010 Harvey Prize in human health by the Technion, Israel's premier institute of technology.

The prize honors Karin's seminal research linking obesity, inflammation and cancer. Specifically, judges noted Karin's "pioneering contributions" to the deciphering of the molecular mechanism used by mammalian cells to react to cytokines (proteins that cause inflammation), to adverse environmental conditions and to various pathogens. "These discoveries," the judges said, have "led to the identification of new target proteins that have recently been used to develop new medications for preventing and treating various malignant tumors."

Karin will accept the Harvey Prize at a ceremony at the Technion in Haifa, Israel on March 15, 2011, along with Alexander Polyakov, a theoretical physicist at Princeton University who is receiving the 2010 Harvey Prize for science and technology, based upon his work in quantum field theory. Each recipient will receive a $75,000 cash award.

At UC San Diego, Karin and colleagues have long been interested in how cells and biological systems function at the molecular level in both healthy and stressed or diseased states. The research has broad, practical implications and applications, notably in issues like obesity and cancer.

"In addition to its well-known contribution to cardiovascular disease and metabolic disorders, such as type II diabetes, obesity has been found to increase cancer risk," said Karin. "Of all cancers, the one most affected by obesity is liver cancer, the third leading cause of cancer-related deaths worldwide. Our work has shown that obesity promotes the development of liver cancer through inflammatory mechanisms similar to those we elucidated earlier in colorectal cancer, another very common inflammation-promoted cancer."

Karin's lab has identified cytokines and responding transcription factors involved in these cancers. Drugs that inhibit activation of a key transcription factor called STAT3 are in development and slated for clinical trials soon.


'/>"/>

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert  

Related medicine news :

1. K-State receives patent for noncontroversial source of stem cells
2. St. Jude researcher receives grant to focus on cancer pharmacogenomics in children
3. Penn receives $12 million NIH grant to research personalized approach to smoking cessation
4. Health IT program at the University of Texas at Austin receives $2.7 million in federal funding
5. University of Minnesota math institute receives $20.5 million NSF grant
6. College Of Medicine receives $54 million grant for asthma research
7. Louisiana Tech kinesiology professor receives national editorial excellence award
8. UofL receives $3.15 million grant from Helmsley Charitable Trust
9. St. Michaels receives prestigious grants to study trauma
10. Doctor at Cincinnati Childrens receives prestigious NIH MERIT Award
11. Research consortium at CHLA receives $410,000 to study leukemia and lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UC San Diego's Karin receives prestigious Harvey Prize
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/25/2016)... ... , ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter ... bar too high can result in disappointment, perhaps even self-loathing. However, those who set ... , Research from PsychTests.com reveals that behind the tendency to set low ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
(Date:6/24/2016)... , June 24, 2016 ... of the "Structural Electronics 2015-2025: Applications, Technologies, ... In-Mold Electronics, Smart Skin, ... Photovoltaics Structural electronics involves electronic ... load-bearing, protective structures, replacing dumb structures such as ...
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
Breaking Medicine Technology: